Lattanzi, Simona http://orcid.org/0000-0001-8748-0083
Trinka, Eugen
Zaccara, Gaetano
Striano, Pasquale
Russo, Emilio
Del Giovane, Cinzia
Silvestrini, Mauro
Brigo, Francesco
Article History
Accepted: 30 November 2021
First Online: 21 January 2022
Declarations
:
: This study was not funded.
: Simona Lattanzi has received speaker's or consultancy fees from Angelini Pharma, Eisai, GW Pharmaceuticals, and UCB Pharma and has served on advisory boards for Angelini Pharma, Arvelle Therapeutics, BIAL, and GW Pharmaceuticals. Eugen Trinka reports personal fees from EVER Pharma, Marinus, Angelini, Arvelle Therapeutics, Argenix, Medtronic, Bial-Portela & Cª, NewBridge, GL Pharma, GlaxoSmithKline, Boehringer Ingelheim, LivaNova, Eisai, Epilog, UCB Pharma, Biogen, Genzyme Sanofi, Takeda, and Actavis; his institution received grants from Biogen, UCB Pharma, Eisai, Red Bull, Merck, Bayer, the European Union, FWF Osterreichischer Fond zur Wissenschaftsforderung, Bundesministerium für Wissenschaft und Forschung, and Jubiläumsfond der Österreichischen Nationalbank outside the submitted work. Gaetano Zaccara has received speaker’s or consultancy fees from Eisai, Jazz Pharmaceuticals, and UCB Pharma and has served on advisory board for GW Pharmaceuticals. Pasquale Striano received fees and research grants from GW Pharmaceuticals, Zogenyx, Biomarin, and Kolfarma. Emilio Russo has received speaker fees or funding from, and has participated in advisory boards for Angelini, Arvelle Therapeutics, Eisai, Kolfarma, Pfizer, GW Pharmaceuticals, UCB Pharma, and Lundbeck. Francesco Brigo acted as a consultant for Eisai. Cinzia Del Giovane and Mauro Silvestrini have no conflicts of interest directly relevant to the content of this study.
: Not applicable.
: Not applicable.
: Not applicable
: Not applicable.
: Not applicable
: SL designed and conceptualised the study, carried out the data analyses, and drafted the manuscript. CDG carried out the data analyses. All authors critically revised the manuscript for important intellectual content. All authors approved the final manuscript for submission and agree to be accountable for all aspects of the work.